Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease.
Davis
R
R
Department of Pharmacology, Parke-Davis Pharmaceutical Research, Ann Arbor, MI 48105.
Raby
C
C
Callahan
M J
MJ
Lipinski
W
W
Schwarz
R
R
Dudley
D T
DT
Lauffer
D
D
Reece
P
P
Jaen
J
J
Tecle
H
H
D000544:Alzheimer Disease / Q000188:drug therapy* / Q000503:physiopathology; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D000242:Cyclic AMP / Q000378:metabolism; D005769:Gastrointestinal Motility / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008253:Macaca mulatta; D051379:Mice; D008810:Mice, Inbred C57BL; D009928:Organ Specificity; D010277:Parasympathomimetics / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D051381:Rats; D011976:Receptors, Muscarinic / Q000145:classification / Q000187:drug effects* / Q000502:physiology
D010277:Parasympathomimetics; D011976:Receptors, Muscarinic; D000242:Cyclic AMP